EGFR-RAD51 fusion variant in lung adenocarcinoma and response to erlotinib: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EGFR-RAD51 fusion variant in lung adenocarcinoma and response to erlotinib: A case report

Published:2018-01 Issue: Volume:115 Page:131-134
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Zhu You-cai,Wang Wen-xian,Xu Chun-wei,Song Zheng-bo,Du Kai-qi,Chen Gang,Lv Tang-feng,Song Yong

Funder

Science and Technology Planning Project of Zhejiang Province

National Clinical Key Specialty Construction Program (2013)

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Cancer statistics, 2017;Siegel;CA. Cancer J. Clin.,2017

2. Cancer statistics in China, 2015;Chen;CA. Cancer J. Clin.,2016

3. EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc. Natl. Acad. Sci. U. S. A.,2004

4. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

5. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N. Engl. J. Med.,2004

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distribution of EGFR fusions in 35,023 Chinese patients with solid tumors-the frequency, fusion partners and clinical outcome;World Journal of Surgical Oncology;2024-07-25

2. Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy;Frontiers in Oncology;2024-03-25

3. Distribution of EGFR fusions in 35,023 Chinese patients with solid tumors-the frequency, fusion partners and clinical outcome;2024-03-25

4. Expanding Broad Molecular Reflex Testing in Non-Small Cell Lung Cancer to Squamous Histology;Cancers;2024-02-23

5. Lung cancer in patients who have never smoked — an emerging disease;Nature Reviews Clinical Oncology;2024-01-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3